Re: Strategy
|
6
|
Resverlogix Corp.
|
Mar 07, 2021 01:11PM
|
Re: Venting Friday!
|
6
|
Resverlogix Corp.
|
Feb 28, 2022 02:51PM
|
Re: What's Next?
|
6
|
Resverlogix Corp.
|
Mar 11, 2016 08:13PM
|
Re: Another quarter and not a peep
|
6
|
Resverlogix Corp.
|
Jan 04, 2023 12:35AM
|
Financial Statements
|
6
|
Resverlogix Corp.
|
Jul 28, 2020 05:21PM
|
Re: Change in Auditors
|
6
|
Resverlogix Corp.
|
Mar 08, 2023 05:32PM
|
Re: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
|
6
|
Resverlogix Corp.
|
May 03, 2019 12:37AM
|
Eversana ValuationCaseStudy
|
6
|
Resverlogix Corp.
|
Jan 03, 2022 11:00PM
|
Re: Question on valuing shares from time of spinoff
|
6
|
Zenith Epigenetics
|
Jul 18, 2018 04:13PM
|
Re: Tired and dissappointed ( not shock ) ...
|
6
|
Resverlogix Corp.
|
May 19, 2016 10:01PM
|
Re: Zenith 500MM Valuation
|
6
|
Zenith Epigenetics
|
Feb 16, 2017 01:00PM
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
6
|
Resverlogix Corp.
|
Apr 21, 2021 10:20AM
|
Re: Did DM show some cards?
|
6
|
Resverlogix Corp.
|
Sep 07, 2020 01:51AM
|
Does anyone know the record date for incentive stock options?
|
6
|
Resverlogix Corp.
|
Sep 29, 2016 08:06PM
|
Re: Just pathetic
|
6
|
Resverlogix Corp.
|
Sep 16, 2024 08:14PM
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
6
|
Resverlogix Corp.
|
Jan 10, 2018 12:43AM
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
6
|
Resverlogix Corp.
|
Jan 10, 2018 12:54AM
|
Re: Total Shares Outstanding 10/15/20
|
6
|
Resverlogix Corp.
|
Oct 15, 2020 03:10PM
|
Re: What happened to our renal trial from 2017???
|
6
|
Resverlogix Corp.
|
Apr 11, 2024 10:30AM
|
Re: We didn't fall from $3 to current levels in a week....
|
6
|
Resverlogix Corp.
|
Aug 28, 2015 11:20PM
|